Umuline



Indications and Reactions:

Role Indications Reactions
Primary
Diabetes Mellitus 17.9%
Dyspnoea 10.7%
Pain 10.7%
Type 2 Diabetes Mellitus 10.7%
Agitation 3.6%
Atrial Fibrillation 3.6%
Back Pain 3.6%
Blood Glucose Increased 3.6%
Blood Pressure 3.6%
Convulsion 3.6%
Hypertension 3.6%
Lung Disorder 3.6%
Pneumonia 3.6%
Prophylaxis 3.6%
Renal Disorder 3.6%
Renal Failure 3.6%
Thrombosis Prophylaxis 3.6%
Type 1 Diabetes Mellitus 3.6%
Incorrect Dose Administered 13.3%
Acute Generalised Exanthematous Pustulosis 6.7%
Coma 6.7%
Drug Rash With Eosinophilia And Systemic Symptoms 6.7%
Hepatitis 6.7%
Hypoglycaemia 6.7%
Hyponatraemia 6.7%
Hypophagia 6.7%
Pruritus 6.7%
Renal Disorder 6.7%
Sensorimotor Disorder 6.7%
Skin Exfoliation 6.7%
Thrombocytopenia 6.7%
Tricuspid Valve Incompetence 6.7%
Secondary
Product Used For Unknown Indication 39.8%
Type 2 Diabetes Mellitus 12.0%
Diabetes Mellitus 8.3%
Type 1 Diabetes Mellitus 7.4%
Asthma 4.6%
Back Pain 4.6%
Lung Disorder 4.6%
Contraception 3.7%
Agitation 1.9%
Diabetic Neuropathy 1.9%
Drug Use For Unknown Indication 1.9%
Sedation 1.9%
Thrombosis Prophylaxis 1.9%
Atrial Fibrillation 0.9%
Hypertension 0.9%
Pain 0.9%
Prophylaxis 0.9%
Renal Failure 0.9%
Renal Impairment 0.9%
Hypoglycaemia 19.2%
Unintended Pregnancy 15.4%
Sensorimotor Disorder 11.5%
Skin Exfoliation 11.5%
Aortic Valve Incompetence 3.8%
Cardiac Arrest 3.8%
Dyspnoea Exertional 3.8%
Hepatitis 3.8%
Hyperthermia 3.8%
Hyponatraemia 3.8%
Mitral Valve Incompetence 3.8%
Rash 3.8%
Renal Failure 3.8%
Streptococcal Infection 3.8%
Thrombocytopenia 3.8%
Concomitant
Product Used For Unknown Indication 24.0%
Drug Use For Unknown Indication 13.2%
Hypertension 12.9%
Bronchitis 5.0%
Type 2 Diabetes Mellitus 4.7%
Pain 4.4%
Infection 4.1%
Immunosuppression 3.8%
Diabetes Mellitus 3.5%
Maternal Exposure During Pregnancy 3.5%
Polytraumatism 3.5%
Prophylaxis 2.2%
Thrombosis Prophylaxis 2.2%
Type 1 Diabetes Mellitus 2.2%
Anaemia 1.9%
Hypokalaemia 1.9%
Pulmonary Embolism 1.9%
Staphylococcal Infection 1.9%
Anxiety 1.6%
Hypercholesterolaemia 1.6%
Vomiting 15.3%
Nausea 8.5%
Thrombocytopenia 8.5%
Posterior Reversible Encephalopathy Syndrome 6.8%
Dyspnoea 5.1%
Haemorrhage Intracranial 5.1%
Rash Erythematous 5.1%
Toxic Epidermal Necrolysis 5.1%
Coma 3.4%
Death 3.4%
Haemoptysis 3.4%
Hepatitis Cholestatic 3.4%
Lung Infection 3.4%
Maternal Exposure During Pregnancy 3.4%
Psoriasis 3.4%
Pulmonary Embolism 3.4%
Renal Failure Acute 3.4%
Syncope 3.4%
Toxic Skin Eruption 3.4%
Tubulointerstitial Nephritis 3.4%